[go: up one dir, main page]

AU5276690A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU5276690A
AU5276690A AU52766/90A AU5276690A AU5276690A AU 5276690 A AU5276690 A AU 5276690A AU 52766/90 A AU52766/90 A AU 52766/90A AU 5276690 A AU5276690 A AU 5276690A AU 5276690 A AU5276690 A AU 5276690A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52766/90A
Inventor
Andrew Gordon Hadley
Belinda Mary Kumpel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NHS Blood and Transplant
Original Assignee
NHS Blood and Transplant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NHS Blood and Transplant filed Critical NHS Blood and Transplant
Publication of AU5276690A publication Critical patent/AU5276690A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU52766/90A 1989-03-17 1990-03-16 Pharmaceutical compositions Abandoned AU5276690A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898906129A GB8906129D0 (en) 1989-03-17 1989-03-17 Pharmaceutical preparations
GB8906129 1989-03-17

Publications (1)

Publication Number Publication Date
AU5276690A true AU5276690A (en) 1990-10-22

Family

ID=10653497

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52766/90A Abandoned AU5276690A (en) 1989-03-17 1990-03-16 Pharmaceutical compositions

Country Status (3)

Country Link
AU (1) AU5276690A (en)
GB (1) GB8906129D0 (en)
WO (1) WO1990011090A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2116246A1 (en) * 1992-06-26 1994-01-06 Roland Beliard Human monoclonal anti-rhesus (d) antibodies and cell lines producing same
DE4224357C2 (en) * 1992-07-23 1997-02-13 Biotest Pharma Gmbh Medicines for the prophylaxis of HDN containing human monoclonal anti-Rhesus (D) antibodies
FR2692786B1 (en) * 1992-06-26 1995-06-16 Aetsrn HUMAN ANTI-RHESUS D MONOCLONAL ANTIBODIES AND CELL LINES PRODUCING THEM.
US8198415B2 (en) 2004-07-20 2012-06-12 Symphogen A/S Anti-rhesus D recombinant polyclonal antibody
ATE443870T1 (en) 2004-07-20 2009-10-15 Symphogen As METHOD FOR CHARACTERIZING A POLYCLONAL CELL LINE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8722019D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722018D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722020D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies

Also Published As

Publication number Publication date
WO1990011090A1 (en) 1990-10-04
GB8906129D0 (en) 1989-05-04

Similar Documents

Publication Publication Date Title
AU4148989A (en) Pharmaceutical compositions
GB9025491D0 (en) Pharmaceutical compositions
AU3674489A (en) Pharmaceutical compositions
GB9004016D0 (en) Pharmaceutical compositions
AU5541290A (en) Pharmaceutical compositions
AU1925488A (en) Pharmaceutical compositions
AU607451B2 (en) Pharmaceutical compositions
AU1928988A (en) Pharmaceutical compositions
ZA905511B (en) Pharmaceutical compositions
AU1635588A (en) Pharmaceutical compositions
AU5276690A (en) Pharmaceutical compositions
AU6012990A (en) Pharmaceutical formulation
HUT56269A (en) Pharmaceutical compositions
AU1507688A (en) Pharmaceutical compositions
ZA905512B (en) Pharmaceutical compositions
GB8909906D0 (en) Pharmaceutical compositions
AU7135091A (en) Pharmaceutical composition
AU4819490A (en) Pharmaceutical compositions
AU5908790A (en) Topical pharmaceutical compositions
AU9016891A (en) Pharmaceutical compositions
GB8917287D0 (en) Pharmaceutical compositions
IE894216L (en) Pharmaceutical compositions
GB8919130D0 (en) Pharmaceutical compositions
GB8916070D0 (en) Pharmaceutical compositions
GB8916069D0 (en) Pharmaceutical compositions